InvestorsHub Logo
icon url

Mikey2222

05/14/15 9:59 AM

#75612 RE: Deep Space #75610

Musclepharm's $17.1M sales backlog definitley backs the growth story. Not only was there $17.1M in revenue not-yet realized (granted it wasn't all from Q4), but it's also missed opportunity. If a store orders more protein when they're low, then run out. Until product is stocked up again this store can't sell anymore of this product even to those customer's who came in specifically for it. It's currently hindering growth and management is to blame. $17.1M is rediculous! I get switching to 1 manufacturer, new product launches, etc., but to me letting it get out of control to that high shows mismanagement.
icon url

TheExpertHimself

05/14/15 10:32 AM

#75614 RE: Deep Space #75610

I bet you have some good brisket at the local cafeteria as well....so, no need for any schwarzenegger selling you beef in a tub from a spoiled brat pirate.